Business Services Industry
Holes in case against Vioxx: Merck.
Australasian Business Intelligence, June, 2009
Byline: Milanda Rout
Jun 22, 2009 (The Australian - ABIX via COMTEX) -- The defence has made its closing arguments in the class action case brought by sufferers from alleged side-effects of the Vioxx anti-arthritis drug against manufacturer Merck. The Federal Court of Australia has heard that the claimants' legal team had failed to conclusively prove that Vioxx was linked to heart problems in the lead client, and instead resorted to flawed facts to sway judge Christopher Jessup.
Publication Date: 23 June 2009
MERCK AND COMPANY INCORPORATED MERCK SHARP AND DOHME (AUSTRALIA) PTY LTD FEDERAL COURT OF AUSTRALIA
Copyright 2009 LexisNexis Australia. All Rights Reserved.
...
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
